Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | HALO | AMGN | GILD | CELG | ILMN |
| Company | Halozyme Therapeutic | Amgen Inc | Gilead Sciences Inc | Celgene Corp | Illumina Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 59.62 | 339.00 | 84.25 | 108.01 | 131.15 |
| High | 59.62 | 339.17 | 84.46 | 108.59 | 131.38 |
| Low | 58.47 | 333.36 | 83.48 | 107.27 | 128.38 |
| Last | 58.67 | 334.95 | 83.89 | 108.24 | 130.48 |
| Change | -0.57 | -2.43 | -0.05 | +0.11 | -0.72 |
| % Change | -0.96% | -0.72% | -0.06% | +0.10% | -0.55% |
| Volume | 447,606 | 614,467 | 3,042,343 | 191,230,496 | 960,232 |
| 20-Day Average Volume | 1,245,016 | 1,794,907 | 7,448,659 | 16,188,930 | 1,440,782 |
| Previous Close | 59.24 | 337.38 | 83.94 | 108.13 | 131.20 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | No | Yes |
| Technicals | |||||
| 20-Day Moving Average | 61.31 | 330.51 | 80.83 | 108.17 | 129.23 |
| 20-Day Raw Stochastic | 1.28% | 76.15% | 87.49% | 63.25% | 61.54% |
| 20-Day Relative Strength | 48.61% | 55.57% | 71.35% | 64.69% | 54.58% |
| Weighted Alpha | +61.61 | +25.55 | +17.96 | +46.30 | +1.31 |
| Today's Opinion | 80% Buy | 100% Buy | 88% Buy | 100% Buy | 72% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 88% Buy | 100% Buy | 72% Buy |
| Last Month's Opinion | 100% Buy | 72% Buy | 72% Buy | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -6.85% since 09/16/24 | -0.27% since 09/16/24 | +0.81% since 09/16/24 | -1.97% since 11/13/19 | +0.49% since 09/16/24 |
| Low | 58.51 on 09/23/24 | 331.00 on 09/18/24 | 82.38 on 09/17/24 | 107.27 on 11/20/19 | 128.38 on 09/23/24 |
| High | 63.50 on 09/18/24 | 339.17 on 09/23/24 | 84.65 on 09/19/24 | 110.53 on 11/14/19 | 136.19 on 09/19/24 |
| 1-Month | |||||
| %Chg | -6.57% since 08/23/24 | +1.69% since 08/23/24 | +9.27% since 08/23/24 | +5.14% since 10/18/19 | -0.94% since 08/23/24 |
| Low | 58.51 on 09/23/24 | 319.00 on 09/06/24 | 76.42 on 08/26/24 | 102.40 on 10/21/19 | 120.51 on 09/12/24 |
| High | 65.53 on 08/29/24 | 339.17 on 09/23/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 136.19 on 09/19/24 |
| 3-Month | |||||
| %Chg | +13.68% since 06/21/24 | +8.50% since 06/21/24 | +18.62% since 06/21/24 | +13.63% since 08/20/19 | +19.89% since 06/21/24 |
| Low | 50.68 on 07/02/24 | 306.11 on 07/03/24 | 66.01 on 07/05/24 | 93.41 on 08/23/19 | 103.52 on 06/28/24 |
| High | 65.53 on 08/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 137.18 on 08/20/24 |
| 6-Month | |||||
| %Chg | +46.21% since 03/22/24 | +21.07% since 03/22/24 | +15.45% since 03/22/24 | +14.14% since 05/20/19 | -5.16% since 03/22/24 |
| Low | 37.73 on 04/19/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 89.08 on 07/23/19 | 100.08 on 05/30/24 |
| High | 65.53 on 08/29/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 110.70 on 11/13/19 | 140.07 on 03/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 7,539,712 | 180,982,432 | 104,576,912 | 77,035,920 | 20,900,160 |
| Shares Outstanding, K | 127,274 | 536,435 | 1,245,853 | 711,714 | 159,300 |
| Annual Sales | 829,250,000 | 28,190,000,000 | 27,116,000,000 | 15,281,000,000 | 4,504,000,000 |
| Annual Net Income | 281,590,000 | 6,717,000,000 | 5,665,000,000 | 4,046,000,000 | -1,161,000,000 |
| Last Quarter Sales | 231,350,000 | 8,388,000,000 | 6,954,000,000 | 4,520,000,000 | 1,112,000,000 |
| Last Quarter Net Income | 93,250,000 | 746,000,000 | 1,614,000,000 | 1,691,000,000 | -1,988,000,000 |
| 60-Month Beta | 1.28 | 0.61 | 0.18 | 1.41 | 1.15 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.91 on 08/06/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 2.99 on 10/31/19 | 0.36 on 08/06/24 |
| Latest Earnings Date | 11/04/24 | 10/29/24 | 11/05/24 | 10/31/19 | 11/14/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 19.83 | 18.06 | 17.85 | 10.99 | 146.08 |